Answer
Breastfeeding should be avoided throughout treatment with talquetamab (Talvey) and for at least 3 months after the last dose.
Sources for this answer
- TALVEY 2 mg/mL solution for injectionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 9Document updated
Sources checked